<DOC>
	<DOCNO>NCT01358474</DOCNO>
	<brief_summary>The purpose study determine participant change dopamine cell brain use DaTSCANâ„¢ brain imaging . Dopamine cell loss occur Parkinson 's disease ( PD ) degenerative Parkinsonian disorder , occur movement disorder essential tremor dystonia . DaTSCAN , also know 123I-Ioflupane , new compound develop General Electric , Inc. approve US Food Drug Administration ( FDA ) help doctor detect change dopamine . This test perform injecting DaTSCAN vein arm , hour , large amount DaTSCAN temporarily accumulate area brain lot dopamine brain cell . Because DaTSCAN contain small amount radioactive iodine , allow doctor use special machine call single photon emission compute tomography ( SPECT ) scan detect location amount radioactivity brain help determine change brain dopamine . It hop study help doctor detect presence dopamine change even symptoms present . This study evaluate DaTSCAN people PD , risk develop PD ( e.g. , idiopathic rapid eye movement sleep disorder ( iRBD ) heterozygous homozygous Gaucher 's disease ( GBA ) mutation ) healthy volunteer .</brief_summary>
	<brief_title>Detecting Dopaminergic Deficits Individuals At-risk Parkinsonism</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Gaucher Disease</mesh_term>
	<mesh_term>Parkinsonian Disorders</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Dopamine Agonists</mesh_term>
	<criteria>Written consent prior study subject surrogate Subjects &gt; /= 18 year &lt; /=85 year Diagnosis Parkinson 's disease , family history Parkinson 's disease , idiopathic rapid eye movement sleep behavioral disorder , agematched control , Gaucher 's disease carrier Gaucher 's gene mutation Females use adequate method birth control childbearing potential Any clinically significant acute unstable physical psychological disease base medical history screen physical examination Any exposure investigational drug within 4 week prior Visit 1 Any exposure radiopharmaceutical within 4 week prior Visit 1 Pregnancy Breastfeeding Severe swallow problem Known sensitivity allergy iodine contain product Advanced liver renal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Parkinson disease</keyword>
	<keyword>idiopathic rapid eye movement sleep disorder</keyword>
	<keyword>Gaucher disease</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>